Steady state bioavailability of a new oral formulation of Hydergine� in geriatric patients-Reference-Cited by-同舟云学术

Steady state bioavailability of a new oral formulation of Hydergine� in geriatric patients

Published:1984 Issue:1 Volume:26 Page:133-135
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

S�rgel F.,Abisch E.,Dennler H. -J.,Lang E.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF00546722.pdf

Reference13 articles.

1. Aellig WH, Nüesch E (1977) Comparative pharmacokinetic investigations with tritium-labelled ergot alkaloids after oral and intravenous administration in man. Int J Clin Pharmacol Ther Toxicol 15: 106?112

2. Berde B, Schild HO (1978) Handbook of experimental pharmacology, vol. 49. Ergot alkaloids and related compounds. Springer, Berlin Heidelberg New York, pp 758?768

3. Bock KD, Welzel D, Dennler HJ (1982) Die Wirkung von Codergocrinmesilat bei älteren Hypertonikern. Muench Med Wochenschr 124: 1095

4. Franz JM, Vonderscher JP, Voges R (1980) Contribution to the intestinal absorption of ergot peptide alkaloids. Int J Pharmacokinet 7: 19?28

5. Horsch A (1982) Prüfung der blutdrucksenkenden Wirkung von Hydergin spezial unter stationären Bedingungen. Eine Pilotstudie. Therapiewoche: 32: 3882?3886

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-Dergocrin;Neuro-Psychopharmaka Ein Therapie-Handbuch;1999

2. Co-Dergocrine Mesylate;Drugs & Aging;1992

3. Co-Dergocrin (Dihydroergotoxin);Neuro-Psychopharmaka;1992

4. Cardiovascular regulation and lipoprotein profile during administration of co-dergocrine in essential hypertension;European Journal of Clinical Pharmacology;1989-02

5. The absolute systemic availability of a new oral formulation of co-dergocrine in healthy subjects;European Journal of Clinical Pharmacology;1988